Ocuphire Pharma Inc.
1.17
-0.16 (-12.03%)
At close: Oct 23, 2024, 8:00 PM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05
Net Income -9.99M 17.89M -56.69M -24.62M -6.17M -14.37M -25.29M -9.31M -14.38M -18.52M -9.50M -11.34M -11.34M -14.02M -6.39M n/a -4.30M -6.35M -6.35M
Depreciation & Amortization 6.00K 4.00K 4.00K 8.00K 3.00K 48.21K 42.36K 32.92K 27.50K 38.55K 37.13K 45.07K 45.07K 50.66K 41.60K n/a 65.07K 96.40K 96.40K
Stock-Based Compensation 3.51M 1.81M 1.91M 1.51M 308.00K 177.32K 1.04M n/a 1.04M 608.79K 565.43K 638.61K 638.61K 584.66K 497.53K n/a 1.12M 436.75K 436.75K
Other Working Capital 477.00K -3.74M -200.00K 354.00K 525.00K 230.69K 655.40K -165.50K -495.94K -1.53M -81.92K 635.50K 635.50K -1.03M -427.01K n/a -31.47K -151.64K -151.64K
Other Non-Cash Items 1.21M 170.00K 1.61M 16.66M 1.41M -4.59M 9.26M -3.72M -2.85M 6.83M 912.01K -4.87M 10.66M 6.40M 701.45K n/a -277.55K 1.68M 1.68M
Deferred Income Tax 77.00K n/a 33.61M -1.50M 499.00K 81.38K -1.35M n/a -202.03K -1.53M -81.92K 635.50K 635.50K -1.03M -427.01K n/a -31.47K -151.64K -151.64K
Change in Working Capital 4.08M -5.55M 181.00K 1.15M 357.00K 149.32K 655.40K -165.50K -293.90K 1.53M 81.92K -635.50K -635.50K 1.03M 427.01K n/a 31.47K 151.64K 151.64K
Operating Cash Flow -1.11M 14.31M -19.37M -6.80M -3.59M -18.94M -15.42M -13.23M -17.35M -11.04M -7.98M -15.53M 2.01K -6.99M -5.15M n/a -3.39M -4.13M -4.13M
Capital Expenditures n/a n/a -100.00K -1.48M -25.00K -39.22K -75.17K -8.67K -62.30K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Acquisitions n/a n/a n/a 2.01M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments n/a n/a n/a n/a -8.89M n/a -21.02M -8.75M -7.91M -26.08M n/a -8.00M n/a -2.35M -1.37M n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a 11.95M 11.72M 13.24M 17.52M n/a n/a 8.50M n/a 75.00K 4.76M n/a n/a n/a n/a
Other Investing Acitivies n/a n/a -100.00K 1.00 8.89M 11.91M 11.64M 4.48M 17.46M 3.41M 845.52K -1.05M n/a 1.62M -2.04M n/a n/a -94.08K -7.92M
Investing Cash Flow n/a n/a -100.00K 539.00K -25.00K 11.91M -9.37M 4.48M 9.55M -22.66M 845.52K -545.92K n/a -660.04K 1.34M n/a n/a -94.08K -7.92M
Debt Repayment n/a -538.00K -108.00K -2.19M -4.70M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a -4.41K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies -278.00K -104.00K -778.00K 2.16M 1.75M 1.22M 5.43M 10.12M 730.94K 6.21M 2.30M 377.20K n/a 3.37M 3.60K n/a n/a 4.97M 4.97M
Financial Cash Flow 8.98M 3.79M 27.61M 21.12M 4.70M 6.87M 22.11M 10.12M 8.17M 24.84M 12.34M 13.60M n/a 12.69M 10.73M n/a 6.72M 13.33M 13.33M
Net Cash Flow 7.87M 18.10M 8.13M 14.86M 1.09M -154.85K -2.68M 1.38M 373.19K -8.86M 5.20M -2.48M 2.01K 5.04M 6.93M n/a 3.33M 9.10M 1.28M
Free Cash Flow -1.11M 14.31M -19.47M -8.27M -3.62M -18.98M -15.50M -13.24M -17.41M -11.04M -7.98M -15.53M 2.01K -6.99M -5.15M n/a -3.39M -4.13M -4.13M